Walleye Capital LLC Cerus Corp Transaction History

Walleye Capital LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$1.66 - $2.42 $216,166 - $315,134	130,221 Added 551.85%	153,818 $290,000
Q4 2023 Feb 14, 2024	SELL	$1.25 - $2.35 $2.23 Million - $4.19 Million	-1,783,721 Reduced 98.69%	23,597 $50,000
Q3 2023 Nov 14, 2023	BUY	$1.5 - $3.07 $2.71 Million - $5.55 Million	1,807,318 New	1,807,318 $2.93 Million
Q1 2023 May 15, 2023	BUY	$2.65 - $3.81 $32,274 - $46,401	12,179 New	12,179 $36,000
Q2 2022 Aug 08, 2022	BUY	$4.41 - $5.69 $128,225 - $165,442	29,076 New	29,076 $154,000
Q3 2021 Nov 15, 2021	SELL	$4.79 - $6.68 $107,396 - $149,772	-22,421 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$5.35 - $6.35 $119,952 - $142,373	22,421 New	22,421 $133,000

156

147M

84.2K

55.5K

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $319M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.